Roles of natural killer cells in immunity to cancer, and applications to immunotherapy

NK Wolf, DU Kissiov, DH Raulet - Nature Reviews Immunology, 2023 - nature.com
Great strides have been made in recent years towards understanding the roles of natural
killer (NK) cells in immunity to tumours and viruses. NK cells are cytotoxic innate lymphoid …

Cancer immune evasion through loss of MHC class I antigen presentation

K Dhatchinamoorthy, JD Colbert, KL Rock - Frontiers in immunology, 2021 - frontiersin.org
Major histocompatibility class I (MHC I) molecules bind peptides derived from a cell's
expressed genes and then transport and display this antigenic information on the cell …

Nanozyme-mediated biocatalysis as a mitochondrial oxidative stress amplifier for tumor nanocatalytic immunotherapy

J Lu, L Song, S Feng, K Wang, Y Mao, Y Gao… - Chemical Engineering …, 2024 - Elsevier
Nanozyme-mediated tumor catalytic therapy has recently garnered attention as a means of
destroying tumor cells and eliciting anti-tumor immune responses. Herein, a copper-doped …

NK cells and cancer: you can teach innate cells new tricks

MG Morvan, LL Lanier - Nature Reviews Cancer, 2016 - nature.com
Natural killer (NK) cells are the prototype innate lymphoid cells endowed with potent cytolytic
function that provide host defence against microbial infection and tumours. Here, we review …

Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects

X Wu, T Li, R Jiang, X Yang, H Guo, R Yang - Molecular cancer, 2023 - Springer
The molecules of Major histocompatibility class I (MHC-I) load peptides and present them on
the cell surface, which provided the immune system with the signal to detect and eliminate …

IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy

T Zhou, W Damsky, OE Weizman, MK McGeary… - Nature, 2020 - nature.com
Cytokines were the first modern immunotherapies to produce durable responses in patients
with advanced cancer, but they have only modest efficacy and limited tolerability,. In an effort …

Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers

JD Beck, M Diken, M Suchan, M Streuber, E Diken… - Cancer Cell, 2024 - cell.com
Major histocompatibility complex (MHC) class I antigen presentation deficiency is a common
cancer immune escape mechanism, but the mechanistic implications and potential …

Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models

C Hotz, TR Wagenaar, F Gieseke, DS Bangari… - Science translational …, 2021 - science.org
Local immunotherapy ideally stimulates immune responses against tumors while avoiding
toxicities associated with systemic administration. Current strategies for tumor-targeted …

[HTML][HTML] The urgent need to recover MHC class I in cancers for effective immunotherapy

F Garrido, N Aptsiauri, EM Doorduijn, AMG Lora… - Current opinion in …, 2016 - Elsevier
Highlights•Tumor immune escape compromises the efficacy of cancer immunotherapy.•Loss
of MHC class I expression is a frequent event in cancer cells.•Three tumor phenotypes …

Natural killer cell memory in infection, inflammation and cancer

A Cerwenka, LL Lanier - Nature Reviews Immunology, 2016 - nature.com
Immunological memory can be defined as a quantitatively and qualitatively enhanced
immune response upon rechallenge. For natural killer (NK) cells, two main types of memory …